Lyme Diagnostics Leverage the Bio-ID800/LAS proteomics platform with an initial tick-borne disease diagnostic to support early and accurate diagnosis and ongoing treatment monitoring for health systems, clinics, and reference laboratories seeking a one-stop solution.

Manufacturing Partnership They maintain device production in Chapel Hill, North Carolina, and engineering and development in Sioux Falls, South Dakota, which suggests opportunities for contract manufacturing, co-development, or OEM partnerships to scale capacity and accelerate go-to-market timelines.

Data & Interoperability Current tech stack indicates opportunities to offer data management, analytics, and interoperability services, including seamless integration with hospital EHR systems to support diagnostic workflows and compliant data handling.

Growth & Collaboration With recent venture financing and revenue, Inanovate is positioned to pursue strategic collaborations such as licensing, co-development, or distribution agreements to accelerate market adoption and revenue growth.

Market Positioning Focused on Lyme and tick-borne diseases in a growing health problem, the company can target mid-sized laboratories and hospital networks, differentiating through a specialized proteomics approach and potential partnerships with research institutions for validation and expansion into related indications.